Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

A case-control study revealed that combinations of drugs for cardiovascular diseases and hypertension were frequently prescribed before a diagnosis of bullous pemphigoid (BP), but the risk associated ...

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the ...

Two everyday medications, pemafibrate and telmisartan, could offer a safer, faster route to treating fatty liver disease.

A common way to manage coronary heart disease is coming under question. To prevent a repeat heart attack or stroke, many patients of a certain age are currently advised to take low-dose aspirin each ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...

A type of drug used to help treat heart attacks does not work on the majority of patients and may actually contribute to hospitalization and death for women, new research has found. However, a study ...

A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...